Effects of Right Ventricular Ejection Fraction on Outcomes in Chronic Systolic Heart Failure

Philippe Meyer(National and Kapodistrian University of Athens), Ali Ahmed(Birmingham VA Medical Center), Marjan Mujib(National and Kapodistrian University of Athens), Michel White(National and Kapodistrian University of Athens), Vera Bittner, Louis J. Dell’Italia(National and Kapodistrian University of Athens), Gilbert J. Perry(National and Kapodistrian University of Athens), Mustafa I. Ahmed(National and Kapodistrian University of Athens), Inmaculada Aban(National and Kapodistrian University of Athens), Ami E. Iskandrian(AstraZeneca (United Kingdom)), Gerasimos Filippatos(National and Kapodistrian University of Athens)
Circulation
January 5, 2010
10.1161/circulationaha.109.887570
Cited by 325

Related Papers

Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC)
|European Heart Journal|2010|2.3k